Home
About
FAQ
History (6)
Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer.
DNA catalysis of a normally disfavored RNA hydrolysis reaction.
Gerancher, Karen
Musculoskeletal System
Kasten, Kevin
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Kevin R. Kasten MD
Title
Associate Professor
Institution
Wake Forest School of Medicine
Address
vCard
Download vCard
Same Department
People who are also in this person's primary department.
Baker, Erin
Colavita, Paul
Gorantla, Vijay
Maiocchi, Sophie
Pandian, Twinkle
Explore
_